Searched for: person:massia02
in-biosketch:yes
Temporal Changes in the Recovery and Utilization of Kidneys Donated After Circulatory Death in the United States
Husain, Syed Ali; Zeiser, Laura; Ishaque, Tanveen; Orandi, Babak J; Levan, Macey L; Stern, Jeffrey M; Motter, Jennifer D; Lonze, Bonnie E; Coons, Barbara E; Lipton, Marissa K; Sommer, Philip M; Bae, Sunjae; Parent, Brendan; Segev, Dorry L; Massie, Allan B; Stewart, Darren E
Kidneys from donation after circulatory death (DCD) donors historically had lower recovery and utilization than kidneys from donation after brain death (DBD) donors. However, the organ shortage and advances in organ preservation have increased interest in DCD transplantation. We used OPTN data to study temporal changes in U.S. DCD kidney recovery and transplantation. The percent DCD among kidney donors increased from 21.0% (Era1: 2016-2019) to 30.6% (Era2: 2020-2022) and 42.4% (Era3: 2023-2025). By 2025Q2, more than half (50.4%) of kidney donors were DCDs. Wide variability persisted across eras in percent DCD by recovering OPO (Era1 range: 0%-38%, Era2: 0%-49%, Era3: 0.4%-60%) and by transplanting center (Era1 range: 0%-48%, Era2: 0%-58%, Era3: 0%-60%). Transplanted DCD kidneys in Era3 (vs Era1 & Era2) were more likely to have donor age >60, diabetes, hypertension, obesity, and death due to cardiovascular disease or stroke; 86.8% were pumped. Though the recovered DCD kidney nonuse rate rose from 20.8% (Era1) to 29.9% (Era2) and 35.4% (Era3), nonused DCD kidney donors were age and had more comorbidities in Era 3 compared to earlier eras. Given that half of kidney donors are now DCD, refinements in DCD donor selection and management are needed to optimize recovery and utilization.
PMID: 42722333
ISSN: 1600-6143
CID: 6072263
National Trends in Consent to Accept Hepatitis C Virus Positive Donor Organs
Massie, Priya; Xue, Ruiqi; Orandi, Babak J; Berger, Jonathan C; Torres-Hernandez, Alejandro; Moazami, Nader; Halazun, Karim J; Natalini, Jake G; Stewart, Darren E; Segev, Dorry L; Massie, Allan B; Lonze, Bonnie E
As hepatitis C virus (HCV) infection is now curable, HCV-positive donor organs have expanded the deceased donor pool. Using OPTN data, we identified adult kidney, liver, heart, and lung candidates listed between 2016-2025 and evaluated rates of consent to accept HCV antibody-positive (Ab+) and HCV viremic (NAT+) organs. Temporal trends were described, and multilevel modified Poisson regression with center-level random effects was used to estimate adjusted risk ratios for candidate factors and quantify center variation using median incidence rate ratios (MIRR). Rates of consent to accept both HCV Ab+ and NAT+ organs rose over time. By the end of follow-up, consent rates for HCV Ab+ organs were 63.1% for kidney, 80.6% for liver, 73.3% for heart, and 72.1% for lung candidates, and consent rates for NAT+ organs were 44.9%, 70.7%, 50.5%, and 46.1%, respectively. Associations between candidate characteristics and consent were small after adjustment for center, whereas center effects were large. For HCV Ab+ organs, MIRRs were 6.31 (kidney), 2.48 (liver), 2.90 (heart), and 4.36 (lung); for NAT+ organs, MIRRs were even higher, 9.65, 3.19, 4.00, and 7.30, respectively, indicating marked between-center variability. Our analyses suggest that access to HCV-positive organs is influenced more by center practices than patient characteristics.
PMID: 42716308
ISSN: 1600-6143
CID: 6072239
Center Geography or Center Practice? Decomposing Geographic Variation in Access to Deceased Donor Liver Transplantation
Ishaque, Tanveen; Liyanage, Luckmini; Espinosa, Luis Arias; Mankowski, Michal A; Halazun, Karim J; Segev, Dorry L; Gentry, Sommer E; Massie, Allan B; Stewart, Darren E
Disparities in deceased donor liver transplantation (DDLT) may be due to geographic imbalances of organ supply-to-demand ratios and/or center organ acceptance practices. We evaluated the relative contribution of centers versus broader geographic units (DSAs/States/OPTN regions/census divisions) to variability of DDLT rate. Using SRTR data on adult, first-time, non-Status1A, period-prevalent waitlist candidates, we conducted multilevel Poisson regression with center-level and donor service area (DSA)-level intercepts to model DDLT rates across three eras: pre-acuity circles (AC)(5/1/2017-4/30/2019), initial post-AC (2/4/2020-2/3/2022), and recent post-AC (02/04/2022-12/31/2024), adjusting for candidate factors. We calculated center-level and DSA-level median incidence rate ratios (MIRRs) and their relative contributions to total geographic variation. DSA-level MIRR declined from 1.471.521.58 to 1.321.371.42 to 1.171.231.28 from pre-AC to initial post-AC to recent post-AC. The center-level, within-DSA MIRR increased from 1.561.611.64 to 1.761.821.84 to 1.921.962.05 across eras. The DSA-level contribution to total center-level variation declined from 43.7% to 21.5% to 8.4% across eras. Similarly, the contribution of other broad, geographic units (States/OPTN regions/census divisions) to total geographic variation in DDLT rates decreased after AC. Further allocation changes are unlikely to substantially reduce geographic disparities because DDLT rate variation is predominantly driven by center-level differences, which were associated with highly variable advanced preservation practices.
PMID: 42716309
ISSN: 1600-6143
CID: 6072240
Allograft Rejection and the Latent HIV Reservoir in Kidney Transplant Recipients with HIV
Sulaiman, Andrew; Tamil Selvan, Miruthula; Yang, Ping; Zhu, Xianming; Eby, Yolanda; Benner, Sarah E; Fernandez, Reinaldo E; Hussain, Sarah; Brown, Diane; Desai, Niraj; Florman, Sander; Rana, Meenakshi M; Friedman-Moraco, Rachel; Pereira, Marcus R; Mehta, Shikha; Stock, Peter; Gilbert, Alexander; Morris, Michele I; Stosor, Valentina; Mehta, Sapna A; Small, Catherine B; Ranganna, Karthik; Santos, Carlos A Q; Aslam, Saima; Malinis, Maricar; Elias, Nahel; Blumberg, Emily A; Massie, Allan; Smith, Melissa L; Morsheimer, Megan; Laird, Gregory M; Siliciano, Robert; Segev, Dorry L; Durand, Christine M; Redd, Andrew D; Tobian, Aaron Ar
People with HIV have higher risk for rejection after kidney transplantation but the mechanism is poorly understood. As HIV latency promotes immune dysregulation and chronic inflammation, we evaluated whether the size of the HIV latent viral reservoir (LVR) at baseline and through 52-weeks is associated with rejection in kidney transplant recipients with HIV from donors with and without HIV. Using the intact proviral DNA assay, we found no differences in the LVR between those who experienced rejection (n=14) versus those who did not (N=55) regardless of donor HIV status. These data support the feasibility of HIV+ to HIV+ organ transplantation. Clinical Trials Registration. NCT03500315.
PMID: 41823991
ISSN: 1537-6613
CID: 6016072
ASO Visual Abstract: Increased Mortality with Surgeon Adoption of Robotic Pancreaticoduodenectomy-A National EHR Study of Outcomes
Donnelly, Conor B; Sacks, Greg D; Hewitt, D Brock; Mankowski, Michal; Gentry, Sommer E; Segev, Dorry L; Massie, Allan B
PMID: 42251211
ISSN: 1534-4681
CID: 6044862
ASO Author Reflections: Mortality During the Real-World Adoption of Robotic Pancreaticoduodenectomy in the USA
Donnelly, Conor B; Sacks, Greg D; Massie, Allan B
PMID: 42265518
ISSN: 1534-4681
CID: 6048452
Biological Mother-To-Child Living Donor Liver Transplantation: Early Vs. Late Postpartum Donation
Kim, Jacqueline I; Patel, Suhani S; Kucirka, Lauren M; Bisen, Shivani S; Vittorio, Jennifer; Griesemer, Adam; Segev, Dorry L; Liapakis, AnnMarie; Massie, Allan B
INTRODUCTION/BACKGROUND:Biological parental donations provide the best option for many pediatric recipients, yielding unique immunological benefits that may enable minimization of immunosuppression in transplanted children. However, living related maternal donation in the postpartum period may introduce an increased risk of donor complications due to the physiological changes of pregnancy and childbirth, and the optimal timing of postpartum living donation is unknown. METHODS:Using US national registry data, we characterized donor and recipient outcomes for pediatric living donor liver transplants performed between 2004 and 2022 where a biological mother donated to a child ≤ 24 months old. RESULTS:Our study population included 256 donor-recipient pairs, with biliary atresia representing the most common indication for transplantation (68.0%). Donors had a median [IQR] age of 30 [25, 34] years, and the median [IQR] time from birth to donation was 9.0 [6.8, 13.0] months. 6.3% of donors experienced a biliary or other complication. When stratifying by donors who donated ≤ 6 vs. > 6 months postpartum, we found no significant differences in donor complications or readmission. Stratified analyses were also comparable for recipient mortality, graft survival, and rejection-free survival. Donors ≤ 6 months postpartum (n = 64) were more likely to experience reoperation than mothers who donated > 6 months postpartum (n = 192) (6.2% vs. 1.0%, p = 0.04). CONCLUSIONS:While maternal living donor liver transplantation is safe for most donors, there is a higher risk of reoperation when donation is performed ≤ 6 months postpartum. Surgeons should be aware that these donors are a higher risk population, requiring discussion upon consent and warranting close post-operative monitoring.
PMCID:13525220
PMID: 42665977
ISSN: 1399-3046
CID: 6071857
Evolving utilization of bariatric surgery since the rise of semaglutide and tirzepatide
Kozato, Akio; Patel, Suhani S; Orandi, Babak J; Massie, Allan B; Mankowski, Michal; Ren-Fielding, Christine; Segev, Dorry L; Parikh, Manish; Chhabra, Karan R
BACKGROUND:Semaglutide and tirzepatide have transformed obesity treatment, but recent changes to bariatric surgery utilization are not well understood. METHODS:Epic's nationwide Cosmos database was queried for patients who underwent primary sleeve gastrectomy or gastric bypass between 2018 and 2025. Patient characteristics including preoperative semaglutide or tirzepatide dispense history were compared using chi-squared and Wilcoxon rank sum tests. Modified Poisson regression was used to identify factors independently associated with pre-surgery GLP-1RA use. Multilevel models were used to examine hospital- and state-level variation in pre-surgery GLP-1RA use. RESULTS:Bariatric surgery utilization increased after Q3 2018, peaked in Q4 2022, and subsequently decreased 39% through Q4 2025. Between Q4 2018 and Q4 2025, the proportion of Hispanic bariatric surgery patients increased (8.1% vs. 16.8%, p < 0.001), and the proportion of patients who received pre-surgery GLP-1RA increased (0.2% vs. 35.3%, p < 0.001). Factors associated with receiving pre-surgery GLP-1RA were year, private insurance, White race, type 2 diabetes (RR 2.94 [2.88-3.00]), older age, sleep apnea, and metabolic dysfunction-associated steatotic liver disease. Factors associated with receiving surgery upfront were Hispanic ethnicity, Black race, and public or no insurance. After adjusting for patient characteristics and year, there was a 15-fold difference in pre-surgery GLP-1RA use between the highest and lowest hospitals (RR 0.19-2.88). CONCLUSIONS:In the Epic Cosmos database, bariatric surgery utilization decreased from 2022 to 2025, and those who underwent bariatric surgery increasingly received GLP-1RA before surgery. Patients who received pre-surgery GLP-1RA were older, White, privately insured, with diabetes and other weight-related comorbidities, while patients who received surgery upfront were Hispanic, Black, and publicly insured. Pre-surgery GLP-1RA use was also driven by center-specific non-clinical factors.
PMID: 42467193
ISSN: 1432-2218
CID: 6067402
Increased Mortality with Surgeon Adoption of Robotic Pancreaticoduodenectomy: A National EHR Study of Outcomes
Donnelly, Conor B; Sacks, Greg D; Hewitt, D Brock; Mankowski, Michal; Gentry, Sommer E; Segev, Dorry L; Massie, Allan B
BACKGROUND:Robotic pancreaticoduodenectomy (RPD) is increasingly performed in the United States. Understanding factors associated with safe adoption of RPD is critical to reducing perioperative mortality during the learning curve. METHODS:Using the Epic Cosmos database, the study identified adult patients (age ≥18 years) who underwent pancreaticoduodenectomy (PD) between 2019 and 2025. Modified Poisson regression was used to assess factors associated with 30-day mortality using adjustment for age, sex, race, ethnicity, insurance, marital status, rural/urban residence, socioeconomic status, and diagnosis. Among surgeons performing two or more RPDs, mortality trends were analyzed across case-number thresholds. Mortality risk was assessed by cumulative RPD and open PD (OPD) experience, with adjustment for age and diagnosis. RESULTS:Among 23,995 patients with a median age of 69 years (interquartile range [IQR], 62-75 years), 1578 (6.6 %) underwent RPD. Use of RPD increased from 4% of PD in 2019 to 10% in 2025. The 30-day mortality was higher for RPD than for OPD (2.7 % vs 2.0 %; adjusted relative risks [aRR], 1.43 (IQR, 1.02-1.95; p = 0.029). In RPD, mortality decreased with increasing surgeon prior experience: 3.9 % (Q1: 0-1 cases), 3.9 % (Q2: 2-4 cases), 2.22 % (Q3: 5-8 cases), 2.67 % (Q4: 9-18 cases), 0.92 % (Q5: 19-71 cases). Increased RPD experience was associated with decreased mortality (per doubling RPD experience: aRR, 0.78 (95 % confidence interval [CI], 0.63-0.96; p = 0.02). The patients who underwent PD between 2023 and 2025 showed no adjusted increase in mortality with robotic technique (aRR, 1.04; 95 % CI, 0.61-1.65; p = 0.85). CONCLUSIONS:Nationwide, adoption of RPD is associated with increased 30-day mortality, which decreases substantially with increasing surgeon RPD experience. These findings suggest that structured, competency-based training pathways are needed to ensure safe dissemination of novel technology, including RPD.
PMID: 42174247
ISSN: 1534-4681
CID: 6038852
Triple Organ Transplantation in the United States After the 2018 Heart Allocation Policy Implementation
Alam, Amit; Low, Yuki; Francis, Jamil; Golombeck, David; Goldberg, Randal; Reyentovich, Alex; Gentry, Sommer; Massie, Allan; Moazami, Nader; Katz, Jason N
PMID: 42641396
ISSN: 2772-963x
CID: 6071773